Jasper Therapeutics Inc (NAS:JSPR)
$ 22.16 0.04 (0.18%) Market Cap: 334.30 Mil Enterprise Value: 218.22 Mil PE Ratio: 0 PB Ratio: 2.95 GF Score: 23/100

Jasper Therapeutics Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 13, 2023 / 08:00PM GMT
Release Date Price: $18.2 (+5.20%)
Jay Olson
Oppenheimer & Co. Inc. - Analyst

Hello, everyone, and welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Jay Olson, one of the biotech analysts at Oppenheimer, and I want to thank you all for joining us here today.

It's my pleasure to welcome Jasper Therapeutics to our conference, and it's an honor to introduce Ronald Martell, the CEO; and Jeet Mahal will also be joining for the Q&A. Jeet is the CFO and Chief Business Officer. So thank you so much, Ron. And with that, I'll turn it over to you.

Ronald Martell
Jasper Therapeutics, Inc. - CEO

Jay, thank you very much for having Jasper here today. And on behalf of all of my colleagues at Jasper, the investigators that have helped us with our clinical trials, and especially the patients who have participated in our clinical trials, I'd really like to thank you for the opportunity to be here today. And I'm excited to talk about the Jasper story, so thank you.

So first, I must say that some of the comments I may make may constitute forward-looking statements. I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot